ArticleInternational journal of clinical oncology2026
Clinical characteristics of newly detected pharyngo-laryngeal lesions during transoral endoscopic surgery.
Article in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in image-enhanced endoscopy have improved early detection of superficial squamous cell carcinomas in the oropharynx, hypopharynx, and larynx. As a minimally invasive treatment, transoral endoscopic surgery offers advantages over (chemo)radiotherapy and open surgery, including preservation of voice and swallowing function and the option of future radiotherapy. However, some lesions remain undetected during preoperative examinations of conscious patients and are identified only intraoperatively under general anesthesia. In this study, we sought to clarify the clinical characteristics of lesions newly detected during surgery.
methodsWe retrospectively reviewed 193 patients with 284 superficial squamous cell carcinoma lesions of the oro-hypopharynx or larynx who underwent transoral endoscopic surgery between January 2016 and December 2024. To identify factors associated with intraoperative detection, newly identified lesions were compared with preoperatively detected lesions in terms of location, tumor size, histopathology, and preoperative endoscopic examination conditions.
resultsAmong the 284 lesions, 24 (8.5%) were newly detected intraoperatively, which were significantly smaller than those detected preoperatively (median: 7.5 vs. 17 mm) and were mainly located on the posterior walls of the oropharynx and hypopharynx. Sixteen lesions were identified using narrow-band imaging (NBI) alone, whereas eight required additional Lugol staining. Lesions requiring Lugol staining were significantly more likely to be carcinoma in situ than invasive carcinoma.
conclusionsIntraoperatively detected lesions were generally smaller and more frequently located on the posterior pharyngeal wall. Given the limitations of conscious endoscopic examinations, meticulous intraoperative inspection using NBI and Lugol staining is essential to avoid overlooking indistinct lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.